Team:Imperial College London/M2/EncapsulationRationale

From 2009.igem.org

(Difference between revisions)
(Encapsulation Rationale)
(Encapsulation Rationale)
Line 45: Line 45:
</tr></table></html>
</tr></table></html>
<br>
<br>
 +
 +
<html><center><a href="https://2009.igem.org/Team:Imperial_College_London/M1#Module2_Contents"><img width=150px src="https://static.igem.org/mediawiki/2009/1/10/II09_TourArrow.png"></a>
 +
</html>
{{Imperial/09/TemplateBottom}}
{{Imperial/09/TemplateBottom}}

Revision as of 12:40, 9 October 2009

II09 Thumb m2.pngModule 2 - Encapsulsation Overview

II09 TimelineM2.png

Encapsulation Rationale

In nature, encapsulation pathways such as spore formation, aliginate biosynthesis and colanic acid production all share one common feature: they require a large number of genes. For this reason, we decided that the best way encapsulate our chassis was via the modulation of an existing pathway.

E.coli naturally produces a harmless acid resistant polymer known as colanic acid. Colanic acid is a polymer of glucose, galactose and glucuronic acid. By tapping into the pathway that initiates colanic acid biosynthesis, we can turn on its production via the modulation of a gene called RcsB.

In nature, colanic acid acts as a binding agent between individual cells over which a biofilm can be formed. While colanic acid itself is harmless, biofilm formation is associated with the production of a number of virulence factors. To prevent biofilm formation from occuring, we have tapped into a second pathway such that our cells become locked into colanic acid production. The gene responsible for preventing biofilm formation is a transcription factor called YgiV.

In nature, colanic acid is associated with but not attached to the cell surface. To facilitate whole cell encapsulation, we have modified a third pathway to fix the colanic acid to the surface of the cell. This involves an enzyme called Rfal.




  About RcsB, YgiV and Rfal.



Mr. Gene   Geneart   Clontech   Giant Microbes